Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProFertil: GnRHa during chemotherapy for fertility preservation in young women with breast cancer
2020-004780-71Phase 3Active
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer, primary ovarian insufficiency (POI) and infertility comparing Pamorelin + chemotherapy with Placebo + chemotherapy (2 arms). Started Dec 2021; status: active.
02
Drugs
Pamorelin
03
Conditions
breast cancerprimary ovarian insufficiency (POI)infertility
Beyond the preview
Go deeper on 2020-004780-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004780-71.